AbbVie and Bristol Myers Squibb are highlighted as two healthcare companies that defy the sector's trend by consistently paying and raising dividends, with AbbVie being a Dividend King and both companies effectively managing challenges such as patent cliffs through strategic innovations and acquisitions.
For a professional investor looking to build a robust dividend portfolio, considering healthcare stocks like AbbVie and Bristol Myers Squibb may be advantageous due to their consistent dividend payouts and strong fundamentals. AbbVie, identified as a Dividend King, demonstrates resilience through strategic acquisitions and a robust product pipeline, while Bristol Myers Squibb offers a high dividend yield of 4.4% and is actively innovating to counteract upcoming patent cliffs. Both companies provide attractive options for long-term, income-focused investment strategies.